Results 31 to 40 of about 1,490 (178)

Advances in Neurosonology 2005 [PDF]

open access: yesStroke, 2006
Most notable research with neurovascular ultrasound in 2005 focused on treatment amplification,1–3 identification of high-risk patients with intracranial stenoses,4 increased carotid intima-media thickness,5,6 monitoring repairs of ascending aorta,7 carotid stenting,8,9 patient selection and outcomes with percutaneous patent foramen ovale closure,10 ...
Andrei V, Alexandrov, Natan M, Bornstein
openaire   +2 more sources

Standards in neurosonology. Part III [PDF]

open access: yesJournal of Ultrasonography, 2016
The paper presents standards related to ultrasound imaging of the cerebral vasculature and structures. The aim of this paper is to standardize both the performance and description of ultrasound imaging of the extracranial and intracranial cerebral ...
Joanna Wojczal   +5 more
doaj   +1 more source

Neurosonological examination: A non-invasive approach for the detection of cerebrovascular impairment in AD

open access: yesFrontiers in Behavioral Neuroscience, 2014
There has been a growing interest in vascular impairment associated with Alzheimer’s disease (AD). This interest was stimulated by the findings of higher incidence of vascular risk factors in AD.
Barbora eUrbanova   +7 more
doaj   +1 more source

Feasibility of transcranial Doppler to evaluate vasculopathy among survivors of childhood brain tumors exposed to cranial radiation therapy. [PDF]

open access: yesPediatr Blood Cancer
Abstract Background The ability of transcranial Doppler (TCD) to detect asymptomatic cerebrovascular disease among childhood brain tumor survivors following exposure to cranial radiation therapy has not been established. Methods Survivors of childhood brain tumors, more than 3 years since diagnosis and exposed to greater than 30 Gy cranial radiation ...
Bowers DC, Johnson MD.
europepmc   +2 more sources

Cross-cultural validation of plasma p-tau217 and p-tau181 as precision biomarkers for amyloid PET positivity: An East Asian study in Taiwan and Korea. [PDF]

open access: yesAlzheimers Dement
Abstract INTRODUCTION Plasma phosphorylated tau (p‐tau) biomarkers have improved Alzheimer's disease (AD) diagnosis, but data from diverse Asian populations are limited. This study evaluated plasma p‐tau217 and p‐tau181 levels in Korean and Taiwanese populations.
Lin YS   +7 more
europepmc   +2 more sources

TOAST Subtypes of Ischemic Stroke and Its Risk Factors: A Hospital-Based Study at Cipto Mangunkusumo Hospital, Indonesia

open access: yesStroke Research and Treatment, 2018
Background and Purpose. Stroke is a leading cause of death and disability, with ischemic stroke as the highest prevalent cases in Indonesia. Ischemic stroke can be classified further into five subtypes according to TOAST classification.
Salim Harris   +5 more
doaj   +1 more source

Quantitative and Qualitative Pain Evaluation in Response to OnabotulinumtoxinA for Chronic Migraine: An Observational Real-Life Study

open access: yesToxins, 2023
(1) Background: Randomized controlled trials and real-life studies demonstrated the efficacy of OnabotulinumtoxinA (OBT-A) for CM prevention. However, no studies specifically addressed its effect on pain’s quantitative intensity and qualitative ...
Claudia Altamura   +8 more
doaj   +1 more source

Impaired Cerebral Haemodynamics in Vascular Depression: Insights From Transcranial Doppler Ultrasonography

open access: yesFrontiers in Psychiatry, 2018
Introduction: Late-life depression is a well-known risk factor for future dementia. Increasing evidences also show a link between cerebral hypoperfusion and neurodegeneration, although data on Transcranial Doppler ultrasonography (TCD)-derived measures ...
Valentina Puglisi   +9 more
doaj   +1 more source

Stroke territory and atherosclerosis in ischemic stroke patients with a history of migraine with aura

open access: yesFrontiers in Neurology, 2023
IntroductionThe mechanisms subtending the increased stroke risk in migraine with aura (MA) are not fully understood. Our study aims to evaluate if the clinical profile in stroke patients with MA differentiates from those without MA.MethodsWe retrieved ...
Claudia Altamura   +15 more
doaj   +1 more source

Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study

open access: yesThe Journal of Headache and Pain, 2021
Background Monoclonal antibodies anti-calcitonin gene-related peptide (mAbs anti-CGRP) pathway are effective and safe on migraine prevention. However, some drug agencies limited these treatments to one year due to their high costs.
Fabrizio Vernieri   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy